ERICA CONLEY: Open Payments
NPI 1972919165 · FLORENCE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,078 in 138 payments from 25 companies in 2025. Trend: 2023 $2,718 · 2024 $3,451 · 2025 $3,078
Food & beverage: $3,078
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 21 | $591 |
| Novo Nordisk Inc | 23 | $424 |
| Sequel Med Tech, LLC | 6 | $204 |
| Amgen Inc. | 13 | $198 |
| Corcept Therapeutics | 8 | $195 |
| Lilly USA, LLC | 11 | $182 |
| GlaxoSmithKline, LLC. | 4 | $180 |
| ABBVIE INC. | 8 | $156 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $136 |
| Tandem Diabetes Care, Inc. | 3 | $127 |
Products named: MINIMED 780G, Ozempic, TWIIST, Korlym, JARDIANCE, t:slim X2 Insulin Pump with Control-IQ, AREXVY, Omnipod.
Industry payments across AL — which companies pay providers there.
